In a worst-case scenario, a baby would get no more than 1.26% of the mother's dose, which is far below the 10% safety threshold
A 2024 study from Epic Research found that people with hypothyroidism who lost more than 5 pounds while taking GLP-1 medications (including semaglutide) saw TSH (thyroid-stimulating hormone) levels decrease by an average of about 0.55 mU/L
And with a bit of filler or botox underneath it will just make the results awesome
Cytotoxicity was assessed by measuring lactate dehydrogenase release as previously described [15] and CSE treated cells under conditions tested did not have changes in cell viability that were statistically significantly different from controls and was greater than 85%
Availability of Retatrutide and Mazdutide Mazdutide is approved in China for chronic weight management and is being studied there and in additional international trials, but it does not have FDA approval and is not available by prescription in the United States
Clinical trials report gallbladder disorders in approximately 1.6-2.6% of patients taking semaglutide for weight loss compared to 0.7-1.2% receiving placebo